🔎 Trials Near Me

Home › Kidney Cancer (Renal Cell Carcinoma) › District of Columbia

Kidney Cancer (Renal Cell Carcinoma) clinical trials in District of Columbia

7 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in District of Columbia.

Cities in District of Columbia

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

  • Sibley Memorial Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07293351

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

  • Georgetown University, Washington D.C.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07188896

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  • MedStar Washington Hospital Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06661720

Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma

  • Sibley Memorial Hospital, Washington D.C.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT06376669

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

  • MedStar Washington Hospital Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT04510597

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.